🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Nonvalvular Atrial Fibrillation

Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure NCT07125417Phase 421 sites📍 Nagoya📍 Toyohashi📍 Matsudo OCEAN-SHD Study Group · Tests: Single Antiplatelet Therapy or No Therapy (Control), Non-Antithrombotic Therapy Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation NCT07458191n/a1 site📍 Sarajevo Bosnalijek D.D · Tests: Apixaban TEE-Guided Versus CCTA-Guided Preprocedural Imaging for Left Atrial Appendage Closure NCT07815119NA1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Transesophageal Echocardiography-Guided Preprocedural Assessment, Cardiac Computed Tomography Angiography-Guided Prepro… Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry NCT06620757n/a22 sites📍 A Coruña📍 Aravaca📍 Barcelona Fundación EPIC · Tests: Single antiplatelet therapy (SAPT)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy